WBR0151: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
|Explanation=The patient in this vignette is suffering from beta-thalassemia major. Beta thalassemia is most often caused by splice site mutations in the beta-globin gene and is prevalent in Mediterranean populations. If both alleles of the beta globin gene have thalassemia mutations, beta thalassemia major is diagnosed. This is a severe microcytic, hypochromic anemia. Untreated, it causes anemia, splenomegaly, and severe bone deformities. It often progresses to death before age 20. A hallmark feature of beta thalassemia major is the “buzz cut” or “hair on end” appearance of the skull on X-ray. This increased spiky opacity is caused by bone marrow expansion in response to chronic anemia. (extramedullary hematopoeisis). Treatment consists of periodic blood transfusion; splenectomy if splenomegaly is present, and treatment of transfusion-induced iron overload. | |Explanation=The patient in this vignette is suffering from beta-thalassemia major. Beta thalassemia is most often caused by splice site mutations in the beta-globin gene and is prevalent in Mediterranean populations. If both alleles of the beta globin gene have thalassemia mutations, beta thalassemia major is diagnosed. This is a severe microcytic, hypochromic anemia. Untreated, it causes anemia, splenomegaly, and severe bone deformities. It often progresses to death before age 20. A hallmark feature of beta thalassemia major is the “buzz cut” or “hair on end” appearance of the skull on X-ray. This increased spiky opacity is caused by bone marrow expansion in response to chronic anemia. (extramedullary hematopoeisis). Treatment consists of periodic blood transfusion; splenectomy if splenomegaly is present, and treatment of transfusion-induced iron overload. | ||
Transfusion associated hemochromatosis is a serious complication of beta-thalassemia, but can be managed with iron chelators such as deferoxamine. Mutations of the HFE gene cause a hereditary form of hemochromatosis. Cure of beta-thalassemia is possible only by bone marrow transplantation. | Transfusion associated hemochromatosis is a serious complication of beta-thalassemia, but can be managed with iron chelators such as deferoxamine. Mutations of the HFE gene cause a hereditary form of hemochromatosis. Cure of beta-thalassemia is possible only by bone marrow transplantation. | ||
|AnswerA=JAK2 gene | |AnswerA=JAK2 gene | ||
|AnswerAExp=Activating mutations in JAK2 cause [[polycythemia vera]] | |AnswerAExp=Activating mutations in JAK2 cause [[polycythemia vera]] | ||
Line 30: | Line 30: | ||
|AnswerBExp=Mutations in the alpha-aminolevulinic acid synthase gene cause a [[sideroblastic anemia]]. | |AnswerBExp=Mutations in the alpha-aminolevulinic acid synthase gene cause a [[sideroblastic anemia]]. | ||
|AnswerC=HFE gene | |AnswerC=HFE gene | ||
|AnswerCExp=HFE | |AnswerCExp=Mutations in the HFE gene cause [[hereditary hemochromatosis]]. Frequent transfusions for beta-thalassemia can cause hemochromatosis. | ||
|AnswerD=Porphobilinogen deaminase | |AnswerD=Porphobilinogen deaminase | ||
|AnswerDExp= | |AnswerDExp=Mutations in the gene encoding porphobilinogen deaminase cause [[acute intermittent porphyria]]. | ||
|AnswerE=ADAMTS13 | |AnswerE=ADAMTS13 | ||
|AnswerEExp=Antibodies against ADAMTS13 cause [[thrombotic thrombocytopenic purpura]]. | |AnswerEExp=Antibodies against ADAMTS13 cause [[thrombotic thrombocytopenic purpura]]. |
Revision as of 01:09, 22 July 2014
Author | PageAuthor::William J Gibson |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Genetics |
Sub Category | SubCategory::Gastrointestinal, SubCategory::Hematology |
Prompt | [[Prompt::A 1-year-old male is evaluated for a well-child exam. The parents report that their child has appeared listless and disengaged. He has failed to begin sitting on his own and responds poorly to verbal cues. The pediatrician notes that the patient is extremely pale. A complete blood count demonstrates a severe microcytic anemia. Hemoglobin electrophoresis shows 95% fetal hemoglobin and 5% hemoglobin alpha 2. HbS and adult hemoglobin are negative. Treatment for this child’s condition is likely to cause symptoms most similar to the genetic disease caused by mutations in which of the following?]] |
Answer A | AnswerA::JAK2 gene |
Answer A Explanation | [[AnswerAExp::Activating mutations in JAK2 cause polycythemia vera]] |
Answer B | AnswerB::Alpha-aminolevulinic acid synthase gene |
Answer B Explanation | [[AnswerBExp::Mutations in the alpha-aminolevulinic acid synthase gene cause a sideroblastic anemia.]] |
Answer C | AnswerC::HFE gene |
Answer C Explanation | [[AnswerCExp::Mutations in the HFE gene cause hereditary hemochromatosis. Frequent transfusions for beta-thalassemia can cause hemochromatosis.]] |
Answer D | AnswerD::Porphobilinogen deaminase |
Answer D Explanation | [[AnswerDExp::Mutations in the gene encoding porphobilinogen deaminase cause acute intermittent porphyria.]] |
Answer E | AnswerE::ADAMTS13 |
Answer E Explanation | [[AnswerEExp::Antibodies against ADAMTS13 cause thrombotic thrombocytopenic purpura.]] |
Right Answer | RightAnswer::C |
Explanation | [[Explanation::The patient in this vignette is suffering from beta-thalassemia major. Beta thalassemia is most often caused by splice site mutations in the beta-globin gene and is prevalent in Mediterranean populations. If both alleles of the beta globin gene have thalassemia mutations, beta thalassemia major is diagnosed. This is a severe microcytic, hypochromic anemia. Untreated, it causes anemia, splenomegaly, and severe bone deformities. It often progresses to death before age 20. A hallmark feature of beta thalassemia major is the “buzz cut” or “hair on end” appearance of the skull on X-ray. This increased spiky opacity is caused by bone marrow expansion in response to chronic anemia. (extramedullary hematopoeisis). Treatment consists of periodic blood transfusion; splenectomy if splenomegaly is present, and treatment of transfusion-induced iron overload.
Transfusion associated hemochromatosis is a serious complication of beta-thalassemia, but can be managed with iron chelators such as deferoxamine. Mutations of the HFE gene cause a hereditary form of hemochromatosis. Cure of beta-thalassemia is possible only by bone marrow transplantation. |
Approved | Approved::Yes |
Keyword | WBRKeyword::Beta thalassemia, WBRKeyword::Blood, WBRKeyword::Iron, WBRKeyword::Hemachromatosis, WBRKeyword::Transfusion, WBRKeyword::Thalassemia, WBRKeyword::Hemoglobin, WBRKeyword::Hemogloniopathy |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |